Amgen: FDA Approves Tezspire For Chronic Rhinosinusitis With Nasal Polyps

Approval Broadens Indication for TEZSPIRE to a Second Disease Characterized by Epithelial-Driven Inflammation THOUSAND OAKS, Calif., Oct. 17, 2025 /PRNewswire/ -- ...
The Malaysian Reserve

FDA APPROVES TEZSPIRE® FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS

Approval Broadens Indication for TEZSPIRE to a Second Disease Characterized by Epithelial-Driven Inflammation THOUSAND OAKS, Calif., Oct. 17, 2025 ...

TEZSPIRE approved in the US for chronic rhinosinusitis with nasal polyps

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

Death of Diane Keaton underscores threat of Pneumonia

Diane Keaton, the Oscar-winning Actress whose career spanned more than five decades with iconic roles in “The Godfather,” ...

Improving Rural Health Care Access: Lung Health Check Launches in Alberta

CNW/ - One in five Albertans live with a lung condition, yet access to critical testing is limited in many rural and remote communities. This lack of ...